Investigating risks of postpartum hemorrhage treatment on future pregnancies

Postpartum hemorrhage (PPH) is a serious condition where a woman experiences significant blood loss after giving birth.

Louisiana legislature approves bill classifying abortion pills as controlled dangerous substances

BATON ROUGE — Two abortion-inducing drugs could soon be reclassified as controlled and dangerous substances in Louisiana under a first-of-its-kind bill that received final legislative

May 23, 2024

FDA Approves Antibiotic Combination for Complicated UTIs

The FDA approved the combination of cefepime and enmetazobactam (Exblifep) for the treatment of adult patients with complicated urinary tract infections, including pyelonephritis. The agency’s

February 24, 2024

Track opioid settlement payouts — to the cent — in your community

State and local governments are receiving billions of dollars in settlements from companies that made, sold, or distributed prescription painkillers and were accused of fueling

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.